Publicacións en colaboración con investigadores/as de University Hospital of Bern (22)

2024

  1. Atrial secondary tricuspid regurgitation: Pathophysiology, definition, diagnosis, and treatment

    European Heart Journal, Vol. 45, Núm. 11, pp. 895-911

  2. Epidemiology, pathophysiology, diagnosis and management of chronic right-sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC

    European Journal of Heart Failure, Vol. 26, Núm. 1, pp. 18-33

  3. Prognostic Implications of Residual Tricuspid Regurgitation Grading After Transcatheter Tricuspid Valve Repair

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 12, pp. 1485-1495

  4. TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation

    European heart journal, Vol. 45, Núm. 8, pp. 586-597

  5. Tricuspid valve disease and cardiac implantable electronic devices

    European Heart Journal, Vol. 45, Núm. 5, pp. 346-365

2022

  1. 2021 ESC/EACTS Guidelines for the management of valvular heart disease

    European Heart Journal, Vol. 43, Núm. 7, pp. 561-632

2021

  1. Anticoagulation in patients with atrial fibrillation and active cancer: An international survey on patient management

    European Journal of Preventive Cardiology, Vol. 28, Núm. 6, pp. 611-621

  2. European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions

    EuroIntervention, Vol. 17, Núm. 5, pp. E367-E375

  3. European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions

    European Heart Journal, Vol. 42, Núm. 16, pp. 1545-1553

  4. Transcatheter treatment for tricuspid valve disease

    EuroIntervention, Vol. 17, Núm. 10, pp. 791-808

2020

  1. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

    European Heart Journal, Vol. 41, Núm. 1, pp. 111-188

  2. The cancer patient and cardiology

    European Journal of Heart Failure, Vol. 22, Núm. 12, pp. 2290-2309

2019

  1. Cardio-oncology services: Rationale, organization, and implementatio: A report from the ESC Cardio-Oncology council

    European Heart Journal, Vol. 40, Núm. 22, pp. 1756-1763

  2. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism

    European Heart Journal, Vol. 40, Núm. 38, pp. 3182-3195

2017

  1. Uaktualnione stanowisko ESC dotyczące stosowania podwójnej terapii przeciwpłytkowej w chorobie wieńcowej w 2017 roku, przygotowane we współpracy z EACTS

    Kardiologia polska, Vol. 75, Núm. 12, pp. 1217-1299

2016

  1. The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes

    EuroIntervention, Vol. 12, Núm. 1, pp. 79-87

2015

  1. Guía de práctica clínica de la ESC sobre revascularización miocárdica, 2014

    Revista Espanola de Cardiologia, Vol. 68, Núm. 2, pp. 144.e-144.e

2014

  1. Local and general anaesthesia do not influence outcome of transfemoral aortic valve implantation

    International Journal of Cardiology, Vol. 177, Núm. 2, pp. 448-454

  2. Management of ST-elevation myocardial infarction according to European and American guidelines

    EuroIntervention

  3. Open issues in transcatheter aortic valve implantation. Part 1: Patient selection and treatment strategy for transcatheter aortic valve implantation

    European Heart Journal, Vol. 35, Núm. 38, pp. 2627-2638